Deborah Knobelman

Insider Reports History

Entity
Individual
Location
C/O Senti Biosciences, Inc., 2 Corporate Drive First Floor, South San Francisco, California
Signature
/s/ Allison Frisbee, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Deborah Knobelman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Kronos Bio, Inc. Chief Financial Officer Common Stock 164K $173K $1.05 Jun 3, 2024 Direct
Kronos Bio, Inc. Chief Financial Officer Employee Stock Option (Right to Buy) 246K Jun 3, 2024 Direct
Senti Biosciences, Inc. Chief Financial Officer, Head of Corporate Development Stock Option (Right to Buy) 152K Feb 1, 2024 Direct
Senti Biosciences, Inc. Chief Financial Officer, Head of Corporate Development Common Stock 131K Feb 1, 2024 Direct

Insider Reports Filed by Deborah Knobelman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KRON Kronos Bio, Inc. Jun 3, 2024 2 $0 4 Jun 4, 2024 Chief Financial Officer
KRON Kronos Bio, Inc. Jun 3, 2024 0 $0 3 Jun 4, 2024 Chief Financial Officer
SNTI Senti Biosciences, Inc. Feb 1, 2024 2 $0 4 Feb 2, 2024 Chief Financial Officer, Head of Corporate Development
SNTI Senti Biosciences, Inc. Feb 1, 2023 1 $0 4 Feb 2, 2023 Chief Financial Officer
SNTI Senti Biosciences, Inc. Oct 3, 2022 2 $0 4 Oct 4, 2022 Chief Financial Officer
SNTI Senti Biosciences, Inc.\ Jun 8, 2022 0 $0 3 Jun 15, 2022 Chief Financial Officer